Edition:
United Kingdom

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

1.15USD
20 Jul 2018
Change (% chg)

$0.02 (+1.77%)
Prev Close
$1.13
Open
$1.12
Day's High
$1.23
Day's Low
$1.12
Volume
15,444
Avg. Vol
55,987
52-wk High
$14.85
52-wk Low
$1.07

Select another date:

Fri, Apr 20 2018

BRIEF-Jaguar Health Files For Resale Of Up To 29.4 Mln Shares Common Stock By The Selling Shareholders

* JAGUAR HEALTH INC FILES FOR RESALE OF UP TO 29.4 MILLION SHARES COMMON STOCK BY THE SELLING SHAREHOLDERS - SEC FILING Source : https://bit.ly/2qOl6Fa Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Jaguar Health Says Unit Signed Agreement With ADAP Crisis Task Force

* JAGUAR INC SAYS NAPO PHARMACEUTICALS HAS SIGNED AN AGREEMENT WITH ADAP CRISIS TASK FORCE

BRIEF-Jaguar Health Inc Files For Non-Timely 10-K With U.S. SEC

* JAGUAR HEALTH INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2GQ2TRx) Further company coverage:

BRIEF-Jaguar Health Says Entered Securities Purchase Agreement With Chicago Venture Partners - SEC Filing​

* JAGUAR HEALTH - ‍ON FEB 26, CO ENTERED SECURITIES PURCHASE AGREEMENT WITH CHICAGO VENTURE PARTNERS - SEC FILING​

BRIEF-Jaguar Health Says Unit Napo Pharmaceuticals Signs Deal With Transition Patient Services To Establish Nationwide Pilot "Mytesi Direct" Program

* JAGUAR HEALTH - UNIT NAPO PHARMACEUTICALS SIGNS DEAL WITH TRANSITION PATIENT SERVICES TO ESTABLISH NATIONWIDE PILOT “MYTESI DIRECT” PROGRAM

BRIEF-Jaguar Health Files For Resale Or Other Disposition Of Up To 6.02 Mln Shares Of Voting Common Stock

* JAGUAR HEALTH INC FILES FOR RESALE OR OTHER DISPOSITION OF UP TO 6.02 MILLION SHARES OF VOTING COMMON STOCK - SEC FILING Source text: [http://bit.ly/2BJoioW] Further company coverage:

BRIEF-Jaguar Health Provides Updates Regarding Programs

* JAGUAR HEALTH PROVIDES UPDATES REGARDING COMMERCIAL, EDUCATIONAL & PRODUCT DEVELOPMENT PROGRAMS AND 2017 RESULTS FOR MYTESI SINCE MERGER (AUGUST–DECEMBER 2017) Source text for Eikon: Further company coverage:

Select another date: